Meridian Bioscience, Inc. – NASDAQ:VIVO
Meridian Bioscience stock price today
$33.97
+33.97
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 8 hours
Meridian Bioscience stock price monthly change
-100.00%
month
Meridian Bioscience stock price quarterly change
-100.00%
quarter
Meridian Bioscience stock price yearly change
-100.00%
year
Meridian Bioscience key metrics
Market Cap | 1.48B |
Enterprise value | 1.44B |
P/E | 21.08 |
EV/Sales | 4.80 |
EV/EBITDA | 63.11 |
Price/Sales | 4.94 |
Price/Book | 4.37 |
PEG ratio | -0.51 |
EPS | 0.97 |
Revenue | 333.01M |
EBITDA | 72.01M |
Income | 42.45M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -0.9% |
Oper. margin | 1.99% |
Gross margin | 56.6% |
EBIT margin | 1.99% |
EBITDA margin | 21.63% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMeridian Bioscience stock price history
Meridian Bioscience stock forecast
Meridian Bioscience financial statements
| Dec 2021 | 88.34M | 15.34M | 17.36% |
|---|---|---|---|
| Mar 2022 | 111.23M | 28.75M | 25.85% |
| Jun 2022 | 67.77M | -7.33M | -10.83% |
| Sep 2022 | 65.67M | 5.70M | 8.69% |
| 2022-11-22 | 0.126 | 0.21 |
|---|---|---|
| 2023-02-02 | 0.15 | -0.67936 |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2018 | 3.35% |
|---|---|
| 2019 | 2.61% |
| 2020 | |
| 2021 | |
| 2022 |
| Mar 2022 | 471810000 | 97.17M | 20.6% |
|---|---|---|---|
| Jun 2022 | 465928000 | 100.38M | 21.54% |
| Sep 2022 | 463097000 | 95.03M | 20.52% |
| Dec 2022 | 456763000 | 116.22M | 25.45% |
| Dec 2021 | 35.55M | -1.70M | -11.08M |
|---|---|---|---|
| Mar 2022 | 30.41M | -1.47M | -24.38M |
| Jun 2022 | 14.40M | -5.70M | 1.63M |
| Sep 2022 | 1.98M | -2.22M | -472K |
Meridian Bioscience alternative data
| Aug 2023 | 690 |
|---|---|
| Sep 2023 | 690 |
| Oct 2023 | 690 |
| Nov 2023 | 690 |
| Dec 2023 | 690 |
| Jan 2024 | 690 |
| Feb 2024 | 690 |
| Mar 2024 | 690 |
| Apr 2024 | 690 |
| May 2024 | 690 |
| Jun 2024 | 690 |
| Jul 2024 | 690 |
Meridian Bioscience other data
97.41%
+4.09%
of VIVO is owned by hedge funds
201
+25
42.88M
+1.81M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2022 | 4028 | 20000 |
| Jun 2022 | 0 | 139603 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | ANDERSON JAMES M. director | Common Stock | 8,500 | $20.38 | $173,230 | ||
Option | ANDERSON JAMES M. director | Stock Options (Right to Buy) | 8,500 | $20.38 | $173,230 | ||
Option | KENNY JOHN P. director, officer.. | Stock Options (Right to Buy) | 61,437 | $10.1 | $620,514 | ||
Option | KENNY JOHN P. director, officer.. | Stock Options (Right to Buy) | 61,437 | $10.1 | $620,514 | ||
Option | KENNY JOHN P. director, officer.. | Stock Options (Right to Buy) | 13,559 | $10.1 | $136,946 | ||
Option | KENNY JOHN P. director, officer.. | Stock Options (Right to Buy) | 13,559 | $10.1 | $136,946 | ||
Sale | KENNY JOHN P. director, officer.. | Common Stock | 61,437 | $30.39 | $1,866,763 | ||
Sale | KENNY JOHN P. director, officer.. | Common Stock | 61,437 | $30.39 | $1,866,763 | ||
Option | KENNY JOHN P. director, officer.. | Common Stock | 61,437 | $10.1 | $620,514 | ||
Option | KENNY JOHN P. director, officer.. | Common Stock | 61,437 | $10.1 | $620,514 |
| Quarter | Transcript |
|---|---|
| Q2 2022 6 May 2022 | Q2 2022 Earnings Call Transcript |
| Q1 2022 4 Feb 2022 | Q1 2022 Earnings Call Transcript |
| Q4 2021 12 Nov 2021 | Q4 2021 Earnings Call Transcript |
| Q3 2021 6 Aug 2021 | Q3 2021 Earnings Call Transcript |
Meridian Bioscience Is Not Your Average Life Science Company
Marketplace Roundtable - Part 6 - Biotech And Healthcare
S&P 500 Stocks With Strong Momentum
The Bottom Fishing Club: OraSure Technologies
If The COVID-19 Delta Variant Spreads This Fall, Meridian Is Still A Buy
Meridian Bioscience: Good Stock, But Margin Of Safety Required
-
What's the price of Meridian Bioscience stock today?
One share of Meridian Bioscience stock can currently be purchased for approximately $33.97.
-
When is Meridian Bioscience's next earnings date?
Unfortunately, Meridian Bioscience's (VIVO) next earnings date is currently unknown.
-
Does Meridian Bioscience pay dividends?
No, Meridian Bioscience does not pay dividends.
-
How much money does Meridian Bioscience make?
Meridian Bioscience has a market capitalization of 1.48B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.76% to 333.02M US dollars. Meridian Bioscience earned 42.46M US dollars in net income (profit) last year or -$0.68 on an earnings per share basis.
-
What is Meridian Bioscience's stock symbol?
Meridian Bioscience, Inc. is traded on the NASDAQ under the ticker symbol "VIVO".
-
What is Meridian Bioscience's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Meridian Bioscience?
Shares of Meridian Bioscience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Meridian Bioscience's key executives?
Meridian Bioscience's management team includes the following people:
- Mr. John P. Kenny Pres, Chief Executive Officer & Director(age: 57, pay: $1,510,000)
- Dr. Lourdes G. Weltzien Ph.D. Executive Vice President of Life Science Bus. Unit(age: 60, pay: $665,660)
- Mr. Tony Serafini-Lamanna Executive Vice President of Diagnostics(age: 62, pay: $600,530)
-
How many employees does Meridian Bioscience have?
As Jul 2024, Meridian Bioscience employs 690 workers.
-
When Meridian Bioscience went public?
Meridian Bioscience, Inc. is publicly traded company for more then 39 years since IPO on 29 Jul 1986.
-
What is Meridian Bioscience's official website?
The official website for Meridian Bioscience is meridianbioscience.com.
-
Where are Meridian Bioscience's headquarters?
Meridian Bioscience is headquartered at 3471 River Hills Drive, Cincinnati, OH.
-
How can i contact Meridian Bioscience?
Meridian Bioscience's mailing address is 3471 River Hills Drive, Cincinnati, OH and company can be reached via phone at +51 32713700.
Meridian Bioscience company profile:
Meridian Bioscience, Inc.
meridianbioscience.comExchange:
NASDAQ
Full time employees:
690
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
3471 River Hills Drive
Cincinnati, OH 45244
Cincinnati, OH 45244
CIK: 0000794172
ISIN: US5895841014
CUSIP: 589584101
